The current market value for biologics used in wound treatment is US$2.09 billion. By the end of 2032, the market for wound care biologics is expected to be worth $5.93 billion, growing at a high CAGR of 11%.
Topical agents and biological skin substitutes are further divisions of wound care biologics products. Biological skin substitute sales are anticipated to grow at a CAGR of 11.5% over the course of the projected period. A wide variety of substances are utilized to close wounds as biological skin substitutes. The main treatment for patients with severe burns is the use of biological skin replacements. The biological skin substitutes also promote the growth of a new, more natural dermis, hastening the healing of wounds.
For more insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7828?SP
Key Takeaways from Market Study
- The global wound care biological products market is expected to reach US$ 5.93 billion by 2032.
- China’s wound care biologics market is expected to increase at an impressive CAGR of 16% from 2022 to 2032.
- Worldwide sales of biologic skin substitutes are predicted to expand at a high CAGR of 11.5% from 2022 to 2032.
- Global demand for topical agents is anticipated to progress at a CAGR of 10% during the forecast period.
Competitive Landscape:
Key players in the wound care biologics market are Acell, Anika Therapeutics, Integra Lifesciences, Kerecis, Marine Polymer Technologies, Mimedx Group, Mölnlycke Health Care AB (Investor AB), Organogenesis, Osiris Therapeutics, and Smith & Nephew.
Sales will rise over the coming years as a result of advancements in biologic wound healing treatment. To create high-quality wound care biologic solutions, major companies in the wound care biologics business spend a lot of money on research and development.
- The tri-layer skin graft Artacent AC, manufactured by the biologics business Tides Medical, was introduced in July 2022 to treat complicated or challenging-to-treat wounds.
- The department of U.S. defence awarded MIMEDX USD 4.6 million in May 2022 to investigate PURION-processed Dehydrated Human Amnion Chorion Membrane (DHACM) to advance the treatment of burns and wounds sustained during warfare.
Key Segments of Wound Care Biologics Industry Research:
· By Product:
- Biologic Skin Substitutes
- Topical Agents
· By Wound Type:
- Ulcers
- Surgical & Traumatic Wounds
- Burns
· By End User:
- Hospitals
- Ambulatory Surgical Centers
- Burn Centers & Wound Clinics
· By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
For in-depth competitive analysis, Buy Now:
https://www.factmr.com/checkout/7828
Questionnaire answered in the Market outlook Report of Wound Care Biologics include:
- What is the key strategy deployed by large players to maximize Wound Care Biologics growth?
- What are the main challenges faced by players in the Wound Care Biologics Demand?
- With the advent of technological advancement, how will the Wound Care Biologics landscape change over the forecast period?
- What does player bring to the table which is unique as a strategy, and is easy to emulate for new investors in the Wound Care Biologics size?
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. We are committed to deliver insights that help businesses gain deeper understanding of their target markets. We understand that making sense of the vast labyrinth of data can be overwhelming for businesses. That’s why focus on offering insights that can actually make a difference to bottom-lines.
Specialties: Competition Tracking, Customized Research, Syndicated Research, Investment Research, Social Media Research, Business Intelligence, Industry Analysis, Thought Leadership.
Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com